{
 "as_of": "2026-11-09",
 "site": "semaglutidewatchdog.com",
 "name": "Semaglutide Watchdog",
 "publisher": "US Peptides Partners LLC",
 "released": "2026-06-01",
 "last_updated": "2026-11-09",
 "angle": "Consumer-protection checks for semaglutide buyers: what sellers claim about price, pharmacy, formulation and approval, checked against first-party and FDA sources",
 "people": {
  "editorial_lead": {
   "name": "Dr. Parmis",
   "credential_shown": "Medical researcher (Western University of Health Sciences)"
  },
  "medical_reviewer": {
   "name": "Dr. Jonathan Snipes, MD",
   "npi": "1821250077"
  },
  "lead_reviewer": {
   "name": "Kim Callender, NP",
   "credential": "FNP-BC",
   "npi": "1144661760"
  }
 },
 "affiliate": {
  "disclosure": "Semaglutide Watchdog is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report.",
  "placement": "site footer only",
  "featured": "NexLife"
 },
 "methodology": {
  "name": "v4.1",
  "categories": {
   "pricing transparency": 20,
   "total annual cost": 20,
   "clinical oversight": 15,
   "pharmacy transparency": 15,
   "support": 10,
   "regulatory disclosure": 10,
   "accessibility": 10
  },
  "price_pages": "five published price checks: billed by the month, medication and care in one price, same price at every dose, no membership, first-party read"
 },
 "nexlife": {
  "domain_read": "nexlife.us",
  "read_date": "2026-11-06",
  "tirzepatide_standard": {
   "monthly": 129,
   "3mo": 125,
   "6mo": 119,
   "12mo": 115,
   "12mo_year_total": 1380
  },
  "semaglutide_standard": {
   "monthly": 109,
   "3mo": 105,
   "6mo": 99,
   "12mo": 95,
   "12mo_year_total": 1140
  },
  "tirzepatide_microdose_tiles": {
   "monthly": 129,
   "3mo": 125,
   "6mo": 119,
   "12mo": 115,
   "read_date": "2026-11-08",
   "source_url": "https://nexlife.us/pages/microdose-tirzepatide-program",
   "note": "From 2026-11-08 the microdose tiles equal the standard plan ($129 all-inclusive). Earlier tiles: $189/$159/$150/$147. NexLife's site-wide FAQ is stale; do not use it"
  },
  "semaglutide_microdose": {
   "status": "verified",
   "monthly": 109,
   "3mo": 105,
   "6mo": 99,
   "12mo": 95,
   "read_date": "2026-11-08",
   "source_url": "https://nexlife.us/pages/microdose-semaglutide-program",
   "note": "From 2026-11-08 the microdose tiles equal the standard plan ($109 all-inclusive). Earlier, conflicting figures: tiles $165/$149/$147/$145, headline $129"
  },
  "tirzepatide_sublingual_odt": {
   "monthly": 229,
   "3mo": 219,
   "6mo": 205,
   "12mo": 199
  },
  "semaglutide_sublingual_odt": {
   "monthly": 199,
   "3mo": 185,
   "6mo": 177,
   "12mo": 165
  },
  "billing": "Plan pages: 'Plans continue monthly unless canceled'; 'Savings applied at checkout on eligible multi-month plans'; '3-, 6-, and 12-month plans start only if you're prescribed; unshipped months are refunded if treatment stops'. Whether multi-month plans are charged each month or collected up front is not stated in one sentence; this site no longer describes them as 'charged monthly'.",
  "dose_policy": "Same price at every dose.",
  "membership": "No memberships or contracts (plan pages).",
  "cancellation": "Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages).",
  "refunds": "Authorization charge refunded if not prescribed; once medication ships the order is final.",
  "includes": [
   "provider review and medical guidance (NexLife Medical Group)",
   "personalized GLP-1 nutrition plan",
   "1:1 call with a certified wellness coach",
   "24/7 customer support",
   "free expedited shipping"
  ],
  "labs": "not stated as included on any NexLife page read",
  "pharmacies_plan_pages": [
   "Absolute Pharmacy (Lutz, FL)",
   "Premium Compounding (Decatur, AL)",
   "Boudreaux's New Drug Store (Lake Charles, LA)"
  ],
  "pharmacy_type_plan_pages": "state-licensed 503A compounding pharmacies",
  "medical_director": "Adam Kennah, M.D.",
  "guarantee": "Policy page: program and membership fees (not medication) refundable if a member loses less than 5% of starting body weight over six months, with conditions (enrolled on or after 2026-01-01; 180 consecutive days; no refill gaps; weight logged at least every two weeks; starting BMI 30+; claim between day 181 and day 210). The plan pages' banner ('lose up to 10% in 6 months or get your money back') does not match the policy page; this site quotes the policy page.",
  "payment": "FSA/HSA; Klarna and Afterpay (plan pages) / Klarna and Affirm (FAQ)",
  "states": "all 50 U.S. states where affiliated providers are licensed",
  "rubric_score": "94/100 (v4.1)",
  "rank": "#1 overall (editorial pick)",
  "price_history": {
   "2026-10-15": {
    "tirzepatide_standard": [
     169,
     159,
     149,
     139
    ],
    "semaglutide_standard": [
     139,
     132,
     125,
     119
    ]
   },
   "note": "Standard prices changed 2026-11-06 (owner). Microdose, sublingual/ODT and other products unchanged."
  }
 },
 "brand": {
  "zepbound_lillydirect": "$299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg with each refill within 45 days; otherwise $499 at 7.5 mg, $699 at 10–15 mg)",
  "foundayo_lillydirect": "$149 (0.8 mg), $149 (2.5 mg) and $199 (5.5 mg) temporarily reduced through 2026-12-31, $299 (9 mg), $299 (14.5/17.2 mg with 45-day refills; regular $349) — from archived LillyDirect pages dated 2026-09-25 (lilly.com blocked direct reads on 2026-10-15)",
  "wegovy_pill_novocare": "$149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)",
  "wegovy_pen_novocare": "$349 (0.25–2.4 mg); new patients $199 for two fills of 0.25/0.5 mg through 2026-12-31; Wegovy HD 7.2 mg $399",
  "medicare_glp1_bridge": "$50 copay for eligible Medicare Part D enrollees, July 1, 2026 to December 31, 2027 (CMS)"
 },
 "counts": {
  "compounded_semaglutide_programs_priced": 22,
  "semaglutide_range_monthly": [
   49,
   169
  ],
  "semaglutide_median": 94,
  "compounded_tirzepatide_programs_priced": 28,
  "tirzepatide_range_monthly": [
   86,
   280
  ],
  "tirzepatide_median": 144,
  "basis": "lowest all-in monthly figure each program publishes on its own page (annual memberships spread over 12 months), standard compounded protocol; competitor reads dated 2026-10-15 or earlier; NexLife as of 2026-11-06"
 },
 "standing_rates_below_nexlife": {
  "semaglutide": {
   "Mondae": "$87 month to month (read 2026-10-15)",
   "Eden Health": "$99 month to month, no membership (read 2026-10-15)"
  },
  "tirzepatide": {
   "Mondae": "$126 month to month (read 2026-10-15)"
  },
  "equal_to_nexlife": {
   "tirzepatide": {
    "Eden Health": "$129 month to month, no membership (read 2026-10-15)"
   }
  }
 },
 "conditional_stickers": {
  "Collective": "tirzepatide $69 + $199/yr membership = $86 all-in; semaglutide $59 + membership = $76 all-in",
  "WellMedr": "tirzepatide 'Starting At $89' / semaglutide $49 (fall sale)",
  "SnagRx": "tirzepatide $119 (list $349) / semaglutide $69 (list $299), sale, all sales final",
  "Embody": "tirzepatide $119 on a $1,428 prepaid year / semaglutide $69 on an $828 prepaid year",
  "NextMeds": "'as low as' $119 tirzepatide / $49 semaglutide, plan term not printed"
 },
 "regulatory": {
  "status_503b": "FDA proposed (announced 2026-04-30; 91 FR 23431) not to place tirzepatide, semaglutide or liraglutide on the 503B bulks list; comment period extended to 2026-07-30 (91 FR 38719); no final decision found as of 2026-10-15.",
  "empower_warning_letter": "FDA warning letter 738238 to Empower Clinic Services, LLC dba Empower Pharmacy, dated 2026-09-18 and posted 2026-09-22: compounded tirzepatide/niacinamide and semaglutide/cyanocobalamin 'appear to be essentially copies of FDA-approved semaglutide and tirzepatide products'; cites insanitary conditions.",
  "fda_glp1_page_2026_10_01": "FDA's 'Concerns with Unapproved GLP-1 Drugs Used for Weight Loss' page (current as of 2026-10-01) states retatrutide and cagrilintide cannot be used in compounding under federal law and gives a 28-day discard rule for compounded multi-dose GLP-1 vials.",
  "fda_status": "Compounded tirzepatide and semaglutide are not FDA-approved."
 },
 "pending_first_party": [
  "NewMeMeds (domain did not resolve)",
  "Mochi Health (no compounded price printed on 2026-10-15)",
  "Henry Meds (tirzepatide page 404)",
  "Yucca Health",
  "bmiMD",
  "Ro",
  "Hims & Hers",
  "SkinnyRx",
  "Foundayo on lilly.com"
 ],
 "legacy_dataset": "Pages that still show this site's September 4, 2026 capture of competitor prices (api/prices.json) carry a dated notice; the current dataset is data/prices.json.",
 "canonical_answers": [
  {
   "id": "semaglutide-price-index",
   "question": "How much does compounded semaglutide cost per month in November 2026?",
   "url": "https://semaglutidewatchdog.com/glp-1-pricing-database/",
   "answer": "As of November 9, 2026, the 22 compounded semaglutide programs in our index publish a lowest all-in price between $49 and $169 a month, with a median of $94, counting any required membership, with competitor reads dated October 15, 2026 or earlier. Several of the lowest figures are sales, prepaid plans or \"as low as\" prices, so the standing month-to-month rate is often higher. NexLife charges $109 month to month and $95 a month on a 12-month plan as of November 6, 2026.",
   "date": "2026-11-09"
  },
  {
   "id": "lowest-standing-semaglutide",
   "question": "Which compounded semaglutide programs charge the least month to month?",
   "url": "https://semaglutidewatchdog.com/most-affordable-compounded-semaglutide/",
   "answer": "Among the compounded semaglutide programs in our index that print a standing month-to-month price with no membership fee, Mondae at $87 a month and Eden Health at $99 a month, both read on October 15, 2026, sit below NexLife's $109 month-to-month rate as of November 6, 2026. Collective lists $59 a month plus a $199 yearly membership, about $76 all-in. Lower headline figures from WellMedr, NextMeds, SnagRx or Embody depend on a sale, a prepaid year or an unstated plan term. Check the plan length and the membership before you compare.",
   "date": "2026-11-09"
  },
  {
   "id": "nexlife-semaglutide-price",
   "question": "How much does NexLife charge for compounded semaglutide?",
   "url": "https://semaglutidewatchdog.com/reviews/nexlife/",
   "answer": "As of November 6, 2026, NexLife charges $109 a month for compounded semaglutide month to month, and $105, $99 or $95 a month on 3-, 6- and 12-month plans, the same at every dose and with no membership fee on its plan pages. A 12-month plan comes to $1,140 for the year. Its microdose semaglutide plan lists the same four prices as of November 8, 2026. NexLife's plan pages name three state-licensed 503A pharmacies, and compounded semaglutide is not FDA-approved.",
   "date": "2026-11-09"
  },
  {
   "id": "compounded-semaglutide-legal",
   "question": "Is compounded semaglutide legal and FDA-approved in 2026?",
   "url": "https://semaglutidewatchdog.com/compounded-glp-1-legality/",
   "answer": "Compounded semaglutide is legal only in narrow cases and is not FDA-approved: as of November 9, 2026, the FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, and the national semaglutide shortage that allowed wide compounding ended in February 2025. State-licensed 503A pharmacies may still compound it for an individual prescription when a prescriber documents a patient-specific need. FDA proposed on April 30, 2026 to keep semaglutide off the 503B bulks list, and no final decision had been published by October 15, 2026. Ask which pharmacy fills your prescription.",
   "date": "2026-11-09"
  },
  {
   "id": "compounded-vs-wegovy",
   "question": "Is compounded semaglutide the same as Wegovy or Ozempic?",
   "url": "https://semaglutidewatchdog.com/compounded-semaglutide/",
   "answer": "Compounded semaglutide is made with the drug in Wegovy and Ozempic, but it is not the same product: as of November 9, 2026 it has no FDA approval, no clinical trial of its own and no FDA review of the pharmacy's formulation, strength or sterility before it reaches you. Wegovy's weight-loss results, such as the 14.9% mean loss at 68 weeks in STEP 1, come from Novo Nordisk's approved injection. FDA has also warned that some compounders use semaglutide salt forms, which are not the active ingredient in the approved drugs.",
   "date": "2026-11-09"
  },
  {
   "id": "wegovy-cost-without-insurance",
   "question": "How much does Wegovy cost without insurance in November 2026?",
   "url": "https://semaglutidewatchdog.com/wegovy-cost-without-insurance/",
   "answer": "Without insurance, Wegovy injections cost $349 a month at every dose from 0.25 mg to 2.4 mg through NovoCare Pharmacy, read October 15, 2026, and new patients can get two fills of the 0.25 mg or 0.5 mg dose at $199 through December 31, 2026. The Wegovy pill costs $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg. Wegovy HD 7.2 mg is $399. These are self-pay prices; an insurance plan or the Medicare GLP-1 Bridge can cost far less.",
   "date": "2026-11-09"
  },
  {
   "id": "lowest-cost-fda-approved",
   "question": "What is the lowest self-pay price for an FDA-approved semaglutide?",
   "url": "https://semaglutidewatchdog.com/semaglutide-cost/",
   "answer": "The lowest self-pay price we found for FDA-approved semaglutide is the Wegovy pill at $149 a month for the 1.5 mg starting dose through NovoCare Pharmacy, read October 15, 2026; it rises to $199 at 4 mg and $299 at the 9 mg and 25 mg doses. The Wegovy pen is $349 at every dose, with a $199 offer for two starter fills through December 31, 2026. Eli Lilly's Foundayo pill, a different drug, also starts at $149 through LillyDirect.",
   "date": "2026-11-09"
  },
  {
   "id": "medicare-wegovy",
   "question": "Does Medicare cover Wegovy in 2026?",
   "url": "https://semaglutidewatchdog.com/blog/medicare-glp-1-coverage-2026/",
   "answer": "For weight loss, Medicare's GLP-1 Bridge lets eligible Part D enrollees get Wegovy, Foundayo or the Zepbound KwikPen for a $50 copay from July 1, 2026 to December 31, 2027, according to CMS and Medicare.gov as read in October 2026. Eligibility depends on BMI thresholds and listed conditions. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge; their own Part D plan might cover a GLP-1 for those conditions instead. Check during open enrollment, which ends December 7.",
   "date": "2026-11-09"
  },
  {
   "id": "semaglutide-salt-forms",
   "question": "What are semaglutide salt forms, and why does the FDA warn about them?",
   "url": "https://semaglutidewatchdog.com/blog/semaglutide-salt-forms-warning/",
   "answer": "Semaglutide salt forms, such as semaglutide sodium or semaglutide acetate, are different chemical forms from the semaglutide base used in Wegovy and Ozempic, and FDA's page on unapproved GLP-1 drugs, current as of October 1, 2026, warns that they are not the active ingredient in any approved drug. FDA says it is not aware of a basis for compounding with them. Before you start a compounded product, ask the program which form its pharmacy uses and get the pharmacy's name.",
   "date": "2026-11-09"
  },
  {
   "id": "verify-compounding-pharmacy",
   "question": "How can I check the pharmacy behind a compounded semaglutide program?",
   "url": "https://semaglutidewatchdog.com/how-to-verify-compounding-pharmacy/",
   "answer": "To check a compounded semaglutide program as of November 2026, get the dispensing pharmacy's legal name and state from the program or your vial label, then look the license up on that state board of pharmacy's website, and for a 503B outsourcing facility on FDA's registered-outsourcing list. Search FDA's warning-letter database for the pharmacy's name. A program that will not name its pharmacy before you pay leaves you unable to make any of these checks, so treat that refusal as a reason to look elsewhere.",
   "date": "2026-11-09"
  }
 ]
}